Stifel Financial’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,577
| Closed | -$18K | – | 3305 |
|
|
2022
Q3 | $18K | Buy |
3,577
+724
| +25% | +$3.64K | ﹤0.01% | 3238 |
|
|
2022
Q2 | $22K | Buy |
2,853
+1,438
| +102% | +$11.1K | ﹤0.01% | 3270 |
|
|
2022
Q1 | $23K | Buy |
1,415
+602
| +74% | +$9.79K | ﹤0.01% | 3336 |
|
|
2021
Q4 | $15K | Buy |
813
+45
| +6% | +$830 | ﹤0.01% | 3349 |
|
|
2021
Q3 | $23K | Buy |
768
+345
| +82% | +$10.3K | ﹤0.01% | 3302 |
|
|
2021
Q2 | $23K | Buy |
423
+2
| +0.5% | +$109 | ﹤0.01% | 3292 |
|
|
2021
Q1 | $25K | Sell |
421
-337
| -44% | -$20K | ﹤0.01% | 3188 |
|
|
2020
Q4 | $28K | Sell |
758
-771
| -50% | -$28.5K | ﹤0.01% | 3013 |
|
|
2020
Q3 | $83K | Buy |
1,529
+778
| +104% | +$42.2K | ﹤0.01% | 2775 |
|
|
2020
Q2 | $189K | Sell |
751
-59
| -7% | -$14.8K | ﹤0.01% | 2599 |
|
|
2020
Q1 | $128K | Buy |
+810
| New | +$128K | ﹤0.01% | 2542 |
|